GLP1R and Hyperglycemia: This incretin response has been suggested to be impaired in type 2 diabetes (T2D), characterized by hyperglycemia resulting from impaired insulin production and insulin resistance in peripheral tissues, as a result of reduced postprandial GLP-1 concentrations [2].